These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2324816)

  • 1. Association between number and sites of new bone scan abnormalities and presence of skeletal metastases in patients with breast cancer.
    Jacobson AF; Stomper PC; Jochelson MS; Ascoli DM; Henderson IC; Kaplan WD
    J Nucl Med; 1990 Apr; 31(4):387-92. PubMed ID: 2324816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone scans with one or two new abnormalities in cancer patients with no known metastases: frequency and serial scintigraphic behavior of benign and malignant lesions.
    Jacobson AF; Cronin EB; Stomper PC; Kaplan WD
    Radiology; 1990 Apr; 175(1):229-32. PubMed ID: 2315486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone scans with one or two new abnormalities in cancer patients with no known metastases: reliability of interpretation of initial correlative radiographs.
    Jacobson AF; Stomper PC; Cronin EB; Kaplan WD
    Radiology; 1990 Feb; 174(2):503-7. PubMed ID: 2296659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone secondaries in breast cancer: the solitary metastasis.
    Boxer DI; Todd CE; Coleman R; Fogelman I
    J Nucl Med; 1989 Aug; 30(8):1318-20. PubMed ID: 2754488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic imaging of bone metastases].
    Scutellari PN; Addonisio G; Righi R; Giganti M
    Radiol Med; 2000 Dec; 100(6):429-35. PubMed ID: 11307503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern and distribution of bone metastases in common malignant tumors.
    Kakhki VR; Anvari K; Sadeghi R; Mahmoudian AS; Torabian-Kakhki M
    Nucl Med Rev Cent East Eur; 2013; 16(2):66-9. PubMed ID: 24068635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer.
    Duncker CM; Carrió I; Berná L; Estorch M; Alonso C; Ojeda B; Blanco R; Germá JR; Ortega V
    J Nucl Med; 1990 Sep; 31(9):1450-5. PubMed ID: 2168473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of 67 Ga and 99mTc (MDP) bone agent. A case report.
    Padmanabhan V; Lakshmanan AV; Shanta V
    Indian J Cancer; 1980 Dec; 17(4):258-60. PubMed ID: 6894438
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of skeletal scintigraphy for oncological practice].
    Kampmann H; Buchelt L
    Rontgenblatter; 1983 Oct; 36(10):342-51. PubMed ID: 6227979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distribution of skeletal metastases in breast and pulmonary cancer: concise communication.
    Wilson MA; Calhoun FW
    J Nucl Med; 1981 Jul; 22(7):594-7. PubMed ID: 7252563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibular findings in carcinoma prostate; a challenging situation for reporting physician.
    Rashid N; Javed MM; Hassan A
    J Pak Med Assoc; 2019 Oct; 69(10):1572-1573. PubMed ID: 31622322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healing flare in skeletal metastases from breast cancer.
    Janicek MJ; Hayes DF; Kaplan WD
    Radiology; 1994 Jul; 192(1):201-4. PubMed ID: 8208938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of quantitative and visual detection of new focal bone lesions.
    Pitt WR; Sharp PF
    J Nucl Med; 1985 Mar; 26(3):230-6. PubMed ID: 3156219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance and outcome of one or two rib lesions on bone scans in breast cancer patients without known metastases.
    Chen HH; Su WC; Guo HR; Lee BF; Su WR; Wu PS; Chiu NT
    Nucl Med Commun; 2003 Nov; 24(11):1167-74. PubMed ID: 14569171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma.
    Jacobson AF; Shapiro CL; Van den Abbeele AD; Kaplan WD
    Cancer; 2001 Jan; 91(1):17-24. PubMed ID: 11148555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small cell lung cancer: radionuclide bone scans for assessment of tumor extent and response.
    Levenson RM; Sauerbrunn BJ; Ihde DC; Bunn PA; Cohen MH; Minna JD
    AJR Am J Roentgenol; 1981 Jul; 137(1):31-5. PubMed ID: 6264774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on prognostic factors in bone metastases of breast cancer].
    Yamashita K
    Nihon Seikeigeka Gakkai Zasshi; 1988 Mar; 62(3):191-203. PubMed ID: 3392448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of bone and liver scans in surveying patients with breast cancer for metastatic disease.
    Evans DM; Wright DJ
    Am Surg; 1987 Oct; 53(10):603-5. PubMed ID: 2823653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Scintigraphic evaluation of the efficacy of treatment of cancer of the breast with bone metastases].
    Gabuniia RI; Godin VP; Gritsaĭ AA; Kirsanov AG; Aplevich NN
    Med Radiol (Mosk); 1989 Apr; 34(4):49-53. PubMed ID: 2540391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of serial bone scans in assessing response of bone metastases to systemic treatment.
    Citrin DL; Hougen C; Zweibel W; Schlise S; Pruitt B; Ershler W; Davis TE; Harberg J; Cohen AI
    Cancer; 1981 Feb; 47(4):680-5. PubMed ID: 6261915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.